MEJLGAARD INVEST ApS: Financial statements 2019
CVR: 10042933
Source: annual report 2019, Danish Business Authority
01/05/2018 – 30/04/2019
MEJLGAARD INVEST ApS (CVR 10042933) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -47,805 and a net result of DKK 1,715,078 compared with DKK 390,673 the year before. Equity in the 2019 report amounted to DKK 12,190,293. The solvency ratio was 88.9%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -47,805
- Profit/Loss
- DKK 1,715,078
- Equity
- DKK 12,190,293
- Total Assets
- DKK 13,718,600
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -48K | 1.7M | 12.2M | 1 |
| 2018 | - | -42K | 391K | 10.6M | 0 |
| 2017 | - | -44K | -455K | 10.3M | 1 |
| 2016 | - | -38K | -298K | 10.8M | - |
| 2015 | - | -26K | 1.9M | 11.2M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout MEJLGAARD INVEST ApS
MEJLGAARD INVEST ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 1985. The company has been dissolved on 3 September 2024. The company was registered under the industry Virksomhedsrådgivning og anden rådgivning om driftsledelse. The company was previously named S.M.J. PHARMA AF 1/10 85 ApS. The company has 1 employee (2023). In 2023, the company reported a gross profit of DKK -35,584 and a net result of DKK 99,498 compared with DKK -493,634 the year before. Equity in the 2023 report amounted to DKK 16,267,957.